Scientists hunt for weak spots in stubborn blood cancers
NCT ID NCT06600568
Summary
This study aims to find new drug combinations that can kill hard-to-treat T-cell leukemia and lymphoma cells. Researchers will test how cancer cells from patients respond to different drug mixes in the lab. The goal is to identify promising treatments for future testing, not to directly treat participants in this study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T-CELL LEUKEMIA/LYMPHOMA, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Nazionale Tumori Fondazione G.Pascale
RECRUITINGNaples, 80100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Istituto Oncologico Veneto
RECRUITINGPadua, 35128, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.